Do you want to volunteer for Clinical Trials? Register now

Volunteer for Clinical Trials

Have you ever thought about taking part in a Medical Trial? By registering your details with MedTrials.co.uk, we are able to send your details directly to companies who are looking for volunteers to take part in their medical research studies.

Information about you is kept on a register that CROs, Pharmaceutical companies and Clinical Investigators can access to contact you regarding individual studies.

Register now >

FDA grants Biohaven’s trigriluzole Fast Track Designation

Biohaven Pharmaceutical announced that the FDA has granted the company Fast Track Designation for Biohaven’s product candidate trigriluzole (BHV-4157) for the potential treatment of Spinocerebellar Ataxia (SCA). Trigriluzole previously received Orphan Drug Designation from the FDA for the treatment of SCA in 2016. Biohaven is currently conducting a phase II/III clinical trial in patients with […]

The post FDA grants Biohaven’s trigriluzole Fast Track Designation appeared first on CenterWatch News Online.

Powered by WPeMatico

News

Type 2 diabetes: Blood sugar pill shows promise

In a 26-week phase II clinical trial for type 2 diabetes patients, glycemic control using semaglutide in pill form was better than using a placebo. Powered by WPeMatico

more >

Cannabis intoxication may be stopped with anti-obesity drug

Intoxication with so-called legal highs may be fatal. But new research may have found the antidote in a slimming drug that blocks cannabinoid receptors. Powered by WPeMatico

more >

Heart failure could be treated using umbilical cord stem cells

In the first study of its kind, researchers find that stem cells derived from the umbilical cord can be used to treat heart failure. Powered by WPeMatico

more >

Poliovirus kills off cancer cells, stops tumor regrowth

A modified poliovirus appears to trigger the body’s anti-tumor immunity. The new study showed promising results in human breast cancer cells and mice. Powered by WPeMatico

more >

Drug resistance: WHO report ‘serious lack of new antibiotics’

A new report from the WHO reveals that the current scope of new antibiotic development is far from what is needed to tackle drug resistance. Powered by WPeMatico

more >

Kyowa Hakko Kirin joins Certara’s Simcyp consortium

Certara, a provider of model-informed drug development and regulatory science, announced that Kyowa Hakko Kirin has joined the Simcyp Consortium and licensed the Simcyp Population-based Simulator. Kyowa Hakko Kirin is the 36th leading biopharmaceutical company and the 11th Japanese pharmaceutical company to join the Consortium. Member companies meet in a pre-competitive environment and work together to […]

more >